IL17A and metabolic dysfunction-associated steatohepatitis: An increased Th17 cell accumulation has been observed in the liver of patients with NASH, relative to those with NAFL, suggesting that intrahepatic Th17 cells or IL-17 may not only promote disease progression but also help discriminate between NAFL and NASH (63).